Building a custom large-scale panel of novel microhaplotypes for forensic identification using MiSeq and Ion S5 massively parallel sequencing systems.


Journal

Forensic science international. Genetics
ISSN: 1878-0326
Titre abrégé: Forensic Sci Int Genet
Pays: Netherlands
ID NLM: 101317016

Informations de publication

Date de publication:
03 2020
Historique:
received: 01 08 2019
revised: 31 10 2019
accepted: 27 11 2019
pubmed: 14 12 2019
medline: 2 2 2021
entrez: 14 12 2019
Statut: ppublish

Résumé

A large number of new microhaplotype loci were identified in the human genome by applying a directed search with selection criteria emphasizing short haplotype length (<120 nucleotides) and maximum levels of polymorphism in the composite SNPs. From these searches, 107 autosomal microhaplotypes and 11 X chromosome microhaplotypes were selected, with well-spaced autosomal positions to ensure their independence in relationship tests. The 118 microhaplotypes were assembled into a single multiplex assay for the analysis of forensic DNA with massively parallel sequencing (MPS). A single AmpliSeq-adapted primer set was made for Illumina MiSeq and Thermo Fisher Ion S5 MPS platforms and the performance of the assay was comprehensively evaluated in both systems. Five microhaplotypes showed critical sequencing failures in both MPS platforms and were removed, while a further 13 required manual checks and the application of sequence quality thresholds in one or both systems to ensure the successful analysis of low-level DNA in these loci. The targeting of short microhaplotype spans during marker selection, with an average length of 51 nucleotides in the 118 loci, led to a high level of sensitivity for the panel when sequencing the very degraded DNA typically encountered in forensic casework and the identification of missing persons.

Identifiants

pubmed: 31835179
pii: S1872-4973(19)30358-8
doi: 10.1016/j.fsigen.2019.102213
pii:
doi:

Substances chimiques

Genetic Markers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102213

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

M de la Puente (M)

Forensic Genetics Unit, Institute of Forensic Sciences, University of Santiago de Compostela, Spain; Institute of Legal Medicine, Medical University of Innsbruck, Austria. Electronic address: m.delapuente.vila@gmail.com.

C Phillips (C)

Forensic Genetics Unit, Institute of Forensic Sciences, University of Santiago de Compostela, Spain. Electronic address: c.phillips@mac.com.

C Xavier (C)

Institute of Legal Medicine, Medical University of Innsbruck, Austria.

J Amigo (J)

Fundación Pública Galega de Medicina Xenómica (FPGMX), Santiago de Compostela, Spain.

A Carracedo (A)

Forensic Genetics Unit, Institute of Forensic Sciences, University of Santiago de Compostela, Spain; Fundación Pública Galega de Medicina Xenómica (FPGMX), Santiago de Compostela, Spain.

W Parson (W)

Institute of Legal Medicine, Medical University of Innsbruck, Austria; Forensic Science Program, Pennsylvania State University, PA, USA.

M V Lareu (MV)

Forensic Genetics Unit, Institute of Forensic Sciences, University of Santiago de Compostela, Spain.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH